跳至主要内容
临床试验/ACTRN12612000010897
ACTRN12612000010897已完成4 期

A randomised, double blind trial of Azithromycin versus Amoxycillin-Clavulate to treat mild to moderate respiratory exacerbations in children with non-Cystic Fibrosis bronchiectasis, Study Two.

Qld Children's Medical Research Institute0 个研究点目标入组 170 人开始时间: 2012年1月4日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 19 Years(—)
性别
All

入选标准

  • Aged less than 18 years.
  • Bronchiectasis, as defined by HRCT scan within the last 5-years OR followed by a respiratory physician for treatment of bronchiectasis if diagnosed earlier.
  • 2 or more respiratory exacerbations of bronchiectasis symptoms in the last 18 months prior to study enrolment.

排除标准

  • Cystic Fibrosis (sweat chloride >35mmol/L or gene mutation). Liver dysfunction. Severe (hypoxic, dyspnoea or hospitalisation required) or recent exacerbation (in the last 4 weeks prior to study enrollment. Known hypersensitivity to macrolides or penicillins. Taking regular maintenance antibiotics of the same class as the investigational antibiotics (macrolides and penicillins), or has taken macrolides or penicillins within 3 weeks of study enrolment. Current or recent (within 4 months prior to study enrolment) identification of pseudomonas organism in the airways. Current treatment for an oncology condition of any kind.

研究者

发起方
Qld Children's Medical Research Institute

相似试验